Fatal mucormycosis after intravascular catheterization in a transplant recipient

Infections in Medicine

Volumn 15, Issue 4, 1998, Pages 252-255

  Ramnath, Nithya ^a   Momin, Feroze ^a   Karanes, Chatchada ^a   Lundstrom, Tammy ^a,b   Chandrasekar, Pranatharthi H ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphotericin B; Catheter; Mucormycosis; Stem cells

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CEFTAZIDIME; CYCLOPHOSPHAMIDE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; DOXORUBICIN; FLUCONAZOLE; ITRACONAZOLE; METHYLPREDNISOLONE; NORFLOXACIN; PREDNISONE; VINCRISTINE; VINCRISTINE SULFATE;

ADOLESCENT; AORTA THROMBOSIS; ARTICLE; AUTOPSY; BONE MARROW TRANSPLANTATION; CASE REPORT; FEMALE; FUNGUS CULTURE; HUMAN; INTRAVASCULAR CATHETER; MUCORMYCOSIS; NONHODGKIN LYMPHOMA; RHIZOPUS; STEM CELL TRANSPLANTATION;

EID: 0031980012     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Morrison VA, McGlave PB: Mucormycosis in BMT population. Bone Marrow Transplant 11:383-388, 1993.
2. Adam RD, Hunter G, DiTomasso J, et al: Mucormycosis: Emerging prominence of cutaneous infections. Clin Infect Dis 19:67-76, 1994.
3. Varaia J, Munoz P, deQuiros JCL, et al: Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter. Eur J Clin Microbiol Infect Dis 14:813-815, 1995.
4. Fisher J, Tuazon CU, Geehhoed GW: Mucormycosis in transplant patients. Am Surg 46:315-322, 1980.
5. Khardori N, Hayat S, Rolston K, et al: Cutaneous Rhizopus and Aspergillus infections in five patients with cancer. Arch Dermatol 125:952-956, 1980.
6. Keys TF, Haldorson RN, Rhodes KH, et al: Nosocomial outbreak of Rhizopus infections associated with Elastoplast wound dressings - Minnesota. MMWR 27:33-34, 1978.
7. Gartenberg G, Bottone EJ, Keusch GT, et al: Hospital-acquired mucormycosis (Rhizopus rhizapodiformis) of skin and subcutaneous tissue. N Engl J Med 299:1115-1118, 1978.
8. Dennis JE, Rhodes KH, Cooney DR, et al: Nosocomial Rhizopus infection (zygomycosis) in children. J Pediatr 96:824-828, 1980.
9. Meyers JD: Fungal infections in bone marrow transplant patients. Semin Oncol 17(suppl 6):S10-S13, 1990.
10. Bowden RA, Meyers JD: Infection complicating bone marrow transplantation, in Rubin RH, Young LS (eds): Clinical Approach to Infections in the Compromised Host, ed 3. New York and London, Plenum Medical Book Company, 1994, pp 601-628.
11. Goodman JL, Winston DJ, Greenfield RA, et al: A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326:845-851, 1992.
12. Slavin MA, Osborne B, Adams R, et al: Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: A prospective, randomized, double-blind study. J Infect Dis 171:1545-1552, 1995.
13. Morrison VA, Haake RJ, Weisdorf DJ: The spectrum of non-candidal fungal infections following bone marrow transplantation. Medicine (Baltimore) 72:78-89, 1993.
14. Abramson E, Wilson D, Arky RA: Rhinocerebral phycomycosis in association with diabetic ketoacidosis: Report of two cases and a review of clinical and experimental experience with amphotericin B therapy. Ann Intern Med 66:735-742, 1967.
15. Abedi E, Sismanis A, Choi K, et al: Twenty-five years' experience treating cerebrorhino-orbital mucormycosis. Laryngoscope 94:1060-1062, 1984.
16. Morduchowicz G, Shmueli D, Shapira Z, et al: Rhinocerebral mucormycosis in renal transplant recipients: Report of three cases and review of the literature. Rev Infect Dis 8:441-446, 1986.
17. Windus DW, Stokes TJ, Julian BA, et al: Fatal Rhizopus infections as hemodialysis patients receiving deferoxamine. Ann Intern Med 107:678-680, 1987.
18. Ringden O, Meunier F, Tollemar J, et al: Efficacy of amphotericin B encapsulated in liposomes in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother 28(suppl B):S73-S82, 1991.
19. Smith PD, Lamerson CL, Banks SM: Granulocyte-macrophage colony stimulating factor augments human monocyte fungicidal activity. J Infect Dis 161:999-1005, 1990.
20. Nemunaitis J, Meyers JD, Buckner CD, et al: Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infection. Blood 78: 907-913, 1991.
21. Bodey GP: The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: A commentary. Eur J Clin Microbiol Infect Dis 13:363-366, 1994.
22. American Society of Clinical Oncology: American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factor: Evidence-based, clinical practice guidelines. J Clin Oncol 12:2471-2508, 1994.
23. Dignani MC, Anaissie EJ, Hester JP, et al: A Phase I/II study of granulocyte-colony stimulating factor-elicited white blood cell transfusions for neutropenia-related fungal infections. Abstracts from the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla., October 1994. Abstract #G 54.